0001193125-26-102172
SEC filingGuardian Pharmacy Services, Inc. reported strong financial results for fiscal year 2025, with revenues of $1.45 billion and net income attributable to the company of $49.2 million. The company generated a gross profit of $292.7 million, representing a gross margin of 20.2%, and operating income of $72.7 million, resulting in an operating margin of 5.0%. Cash flow from operations was robust at $100.3 million, significantly exceeding net income due to non-cash adjustments including $22.3 million in depreciation and amortization and $13.8 million in share-based compensation. The company maintained a solid balance sheet with total assets of $412.7 million, including $65.6 million in cash and cash equivalents, and total liabilities of $194.7 million, resulting in a healthy equity position of $217.9 million. The company invested $19.5 million in property and equipment and $13.4 million in acquisitions during the year, while also repurchasing $29.0 million of common stock. These results demonstrate the company's operational efficiency and financial stability in the pharmacy services sector.
Guardian Pharmacy Services, Inc. delivered solid financial performance for fiscal year 2025, reporting revenues of $1.45 billion and net income attributable to the company of $49.2 million. The company achieved operating income of $72.7 million on gross profit of $292.7 million, representing a gross margin of 20.2% and operating margin of 5.0%. Earnings per share were $1.00 for both basic and diluted calculations, based on weighted-average shares outstanding of 62.4 million basic and 63.3 million diluted. The company's effective tax rate was approximately 33.4% based on provision for income taxes of $24.5 million relative to income before taxes of $73.4 million. Operating cash flow was particularly strong at $100.3 million, significantly exceeding net income due to substantial non-cash adjustments including $22.3 million in depreciation and amortization and $13.8 million in share-based compensation expense.
The company reported total revenues of $1.45 billion for fiscal year 2025. Cost of goods sold was $1.16 billion, resulting in gross profit of $292.7 million. The document does not provide segment breakdowns, geographic mix, or specific growth drivers beyond the aggregate financial figures presented in the XBRL data. No information is provided about revenue composition by business segment, customer type, or geographic region. The filing focuses on consolidated financial results without detailed revenue segmentation in the provided content.
Guardian Pharmacy Services achieved a gross margin of 20.2% for fiscal year 2025, calculated from gross profit of $292.7 million on revenues of $1.45 billion. Operating margin was 5.0%, derived from operating income of $72.7 million. Selling, general, and administrative expenses totaled $220.0 million, representing 15.2% of revenue. Other expenses included interest expense of $665,000 and other expense (income), net of $1.4 million, totaling $722,000 in other expenses. The company's net income margin was 3.4% based on net income attributable to Guardian Pharmacy Services, Inc. of $49.2 million. No prior period margin data is provided for comparison in the document.
The company generated strong operating cash flow of $100.3 million, with key adjustments including $22.3 million in depreciation and amortization, $13.8 million in share-based compensation, and $4.6 million in provision for losses on accounts receivable. Investing activities used $32.2 million, primarily for purchases of property and equipment ($19.5 million) and payments for acquisitions ($13.4 million). Financing activities used $7.1 million, including $29.0 million in proceeds from equity offering offset by $29.0 million in repurchase of common stock. Free cash flow, calculated as operating cash flow ($100.3 million) minus purchases of property and equipment ($19.5 million) and payments for acquisitions ($13.4 million), was $67.4 million. The balance sheet shows total assets of $412.7 million, including current assets of $221.6 million with $65.6 million in cash and cash equivalents. Total liabilities were $194.7 million, with current liabilities of $160.7 million. Equity totaled $217.9 million, including retained earnings of $66.3 million and additional paid-in capital of $139.4 million.
The document does not contain management guidance, strategic priorities, or specific risk factors in the provided content. No forward-looking statements, projections, or outlook commentary is included in the XBRL financial data or document text provided. The filing presents historical financial results for fiscal year 2025 without discussion of future expectations, strategic initiatives, or identified risk factors that would typically appear in the Management's Discussion and Analysis or Risk Factors sections of a 10-K filing.